Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04661059

Study of Late-foetal Human Organ Development

Knowledge about abnormal organ development is important to understand pathology and to develop novel treatment approaches for individuals with congenital and acquired disease. Most of our current understanding is based on examination of tissues from the embryo and early fetus, collected from women undergoing termination of pregnancy in the first trimester (third) of pregnancy. There is very little known about normal and abnormal organ development from a developmental perspective during the crucial last two-thirds of pregnancy when much remodelling of fetal tissues occurs. We aim to collect tissue from a variety of developing fetal organs in the last two-thirds of pregnancy from women who decide to undergo a termination of pregnancy and who wish to undergo a clinical fetal postmortem (PM) examination.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University College Hospitals NHS Foundation Trust

London, United Kingdom

Location status: Recruiting

Location contact

Sarah Gibbon

CONTACT

[email protected]

+44 20 3456 7890

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥18 years old pregnant women who attend the Fetal Medicine Unit for concerns about a fetal abnormality where they decide to proceed to termination of pregnancy

Exclusion criteria

  • Screening labs positive for maternal HIV, Hepatitis B and Hepatitis C, Chlamydia and Herpes.
  • Subject unable to make an informed decision about termination of pregnancy.

Treatment and study plan

Primary outcomes

  1. Cellular maturity

    Time frame: Immediately after tissue collection

    Immunofluorescence staining

Study contacts

Contact information is provided by the study sponsor or research team.

Sarah Gibbon

CONTACT

[email protected]

+44 20 3456 7890

Sponsors and collaborators

Lead sponsor

University College London Hospitals

Other

Registry information

Important dates

Study start
2022
Primary completion
2024
Study completion
2040
First posted
Dec 9, 2020
Registry last updated
Dec 5, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.